Risk, Progressive Licensing and the Health Benefits Lost by Over-Regulating New Drugs

was also the Institute’s President and CEO (2010 and 2012). Dr. Skinner has a B.A. from the University of Windsor, an M.A. through joint studies between the University of Windsor and Wayne State University in Detroit (Michigan), and a Ph.D. from the University of Western Ontario, where he has lectured in both the Faculty of Health Sciences and the Department of Political Science. Dr. Skinner has authored or co-authored approximately 50 major original pieces of applied economics and public policy research. In 2003 he was a co-winner of the Atlas Economic Research Foundation’s Sir Antony Fisher Memorial Award for innovative projects in public policy. Dr. Skinner’s book, Canadian Health Policy Failures: What’s wrong? Who gets hurt? Why nothing changes, was a finalist for Atlas’ 2009 Fisher book prize. His research has been published through several think-tanks including the Fraser Institute (Vancouver), the Atlantic Institute for Market Studies (Halifax), the Pacific Research Institute (San Francisco), the American Enterprise Institute (Washington, D.C.) and the Israel National Institute for Health Policy Research (Israel). His work has also been published in several academic journals including Economic Affairs, Pharmacoeconomics and Alimentary Pharmacology & Therapeutics. Dr. Skinner appears and is cited frequently as an expert in the Canadian, American, and global media. He has presented his research at conferences and events around the world, including testifying before the House of Commons Standing Committee on Health in Ottawa, and briefing bi-partisan Congressional policy staff at the U.S. Capitol in Washington, D.C.